United States · Markets & Finance · Morningstar

Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

Published by Morningstar · United States 9 h ago

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in ...

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

NYT Business

White House Filing Claims President Has Authority to Bar News Outlets

Quartz

Power Play

Seeking Alpha

Oil prices drop as G7 nations pledge to release diesel stocks; Saudis said planning attack on Houthis

Fortune

Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’

Business Insider

OpenAI safety leader David Robinson resigns as the team's upheaval mounts

CNBC